CMS demands hospital data on gender-affirming care for minors ("oversight initiative")

CMS sent letters to selected hospitals providing pediatric gender-affirming care, demanding within 30 days: informed-consent policies and protocols for minors with gender dysphoria; planned changes to clinical practice guidelines in light of the HHS review; evidence of adverse events including detransition-related harm; and complete financial data (billing codes, revenue since 2020, operating margins, forecasts) for federally paid pediatric procedures. CMS's newsroom framed the effort as an oversight initiative into hospitals performing "experimental sex trait modification procedures." The demands functioned as investigative discovery preceding the December 2025 rulemakings and August 2026 fraud referrals.